BRCA1 is making headlines again—linked to breast cancer risk. It’s a key tumor suppressor gene, crucial for DNA repair and cancer prevention.
The UK National Screening Committee recommends against mass prostate screening due to risks outweighing benefits, but proposes targeted screening for high-risk groups, including men with BRCA mutations. The decision follows ongoing debates and new research into screening methods and risks.